+++
title = "BioAdaptives, Inc. Announces National Launch of NeuroRush(TM) in 2025"
date = "2025-07-16T14:15:22Z"
draft = false
summary = "BioAdaptives, Inc. is set to launch NeuroRush(TM), a nootropic supplement aimed at enhancing cognitive functions, nationally in late summer 2025, following its success in test markets."
description = "BioAdaptives announces NeuroRush(TM), a nootropic for mental clarity and stress resilience, launching in 2025. Discover how it's set to transform cognitive health."
source_link = "https://rss.investorbrandnetwork.com/iw/investornewsbreaks-bioadaptives-inc-otc-pink-bdpt-prepares-for-national-launch-of-neurorushtm-nootropic-in-late-summer-2025/"
enclosure = "https://cdn.newsramp.app/genai/images/257/16/79ef17bebbbcc20277d090d274c20520.png"
article_id = 106823
feed_item_id = 17095
url = "/202507/106823-bioadaptives-inc-announces-national-launch-of-neurorushtm-in-2025"
qrcode = "https://cdn.newsramp.app/ibn/qrcode/257/16/voltg6M5.webp"
source = "InvestorBrandNetwork (IBN)"
+++

<p>BioAdaptives, Inc. (OTC Pink: BDPT) has revealed plans for the national launch of NeuroRush(TM), its cutting-edge nootropic supplement, scheduled for late summer 2025. This product, available in two versions—one containing natural caffeine and another caffeine-free—is designed to bolster mental clarity, cognitive endurance, and stress adaptability. NeuroRush(TM) incorporates clinically researched ingredients like Rhodiola, Ashwagandha, and Bacopa, providing a stimulant-free option for those looking to support their brain health.</p><p>The national rollout decision comes after NeuroRush(TM) achieved notable success in test markets, where it garnered positive consumer feedback and demonstrated effective performance. The supplement's adaptogen-based formulation responds to the increasing consumer preference for natural cognitive enhancement solutions that avoid the negative side effects often linked with stimulants. BioAdaptives, Inc. intends to distribute NeuroRush(TM) through online platforms and select wellness partners, aiming to make it widely accessible to individuals focused on improving their cognitive abilities and general health.</p><p>For additional details about the product and its upcoming launch, visit <a href='https://ibn.fm/2CwVh' rel='nofollow' target='_blank'>https://ibn.fm/2CwVh</a>.</p>